Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

European Research Council grant · Running

CatchTheWave Single-cell OMICS-informed in vitro models of human development

Coordinator
Goeteborgs Universitet, Sweden
Runs
1 September 2026 to 31 August 2031
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101221419

What the project is doing

In the project's own words, from its summary on CORDIS.

From immunotherapy to restoring neural function in Parkinson’s disease, cell-based therapies are shaping medicine. Human pluripotent stem cells (hPSCs) could be an invaluable resource, given their unlimited in vitro self-renewal and ability to differentiate into any cell-type. However, in vitro hPSC-derived cells show defective performance in transplantation assays. Using the long-sought in vitro production of hematopoietic stem cells (HSCs) as a model, I propose a strategy to assess and rectify the accuracy of hPSC differentiation protocols in recapitulating embryonic cell fate decision processes:AIM1 Establish an analysis workflow to systematically compare hPSC-derived developmental trajectories with in vivo mammalian embryonic development, using time-resolved single-cell RNA sequencing (scRNAseq) data.

I will benchmark an hPSC differentiation dataset featuring emergence of an HSC signature against a range of published developmental datasets, including both human fetal samples and animal models. AIM2 Probe intrinsic variability of embryoid body (EB)-based hPSC differentiation by integrating cell-type composition (by scRNAseq), time-lapse secretome and morphology of 24 individual EBs. I will thus identify cell-types and secreted factors enriched in the rare EBs comprising an HSC signature.

AIM3 Determine the functional relevance of genes identified as in vitro de-regulated (Aim 1) and/or associated with HSC signature emergence in vitro (Aim 2) using a targeted genetic screen in hPSC differentiation followed by robust transplantation in immunodeficient mice. AIM4 Define the cell autonomous role of genes with confirmed functional relevance for production of HSCs from hPSC (Aim 3) by multiomic profiling of mosaic EBs.

By leveraging the rise in single-cell developmental Atlases, I will obtain robust generation of hPSC-derived HSCs through innovative declinations of EB-based hPSC differentiation, establishing a new paradigm towards clinical translation of hPSCs.

Topics

Who is involved

OrganisationCityCountryRole
Goeteborgs UniversitetGoeteborgSwedenCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS